Carter Ledyard & Milburn LLP advised PainReform Ltd. on the deal. PainReform Ltd., a clinical stage Israeli biotechnology company focused on the reformulation of established therapeutics,...
PainReform Ltd.’s $20 Million IPO
Accentcare’s Joint Venture With Fairview Health Services
Sheppard, Mullin, Richter & Hampton LLP advised AccentCare Inc. on the deal. AccentCare Inc., a national leader in post-acute healthcare, announced its joint venture transaction with...
3A Composites USA’s Acquisition Of Newell Brands Inc.
Moore & Van Allen PLLC advised 3A Composites USA Inc. on the deal. 3A Composites USA Inc., a subsidiary Schweiter Technologies AG (SWX: SWTQ) announced the...
QuantumScape’s Merger With Kensington Capital Acquisition Corp
Wilson Sonsini Goodrich & Rosati advised QuantumScape Corporation on the deal, while Hughes Hubbard served as legal adviser to Kensington Acquisition Corp. QuantumScape Corporation, a developer...
Immunovant’s $200 Million Common Stock Offering
Latham & Watkins represented the underwriters in the transaction. Immunovant, Inc. executed its underwritten public offering of 5,270,093 shares of its common stock at a price...
Morgan Stanley’s Sale of 522 Fifth Avenue
Fried Frank acted as counsel to Morgan Stanley in the transaction. Morgan Stanley executed its sale-leaseback of the office portion of 522 Fifth Avenue in New...
Episerver’s Acquisition Of Optimizely
Fenwick & West LLP advised Optimizely, while Willkie represented Episerver on the deal. Optimizely, a leader in experimentation and optimization, announced its pending acquisition by Episerver, a...
Flying Eagle Acquisition Corp.’s Business Combination With Skillz
White & Case LLP advised Flying Eagle Acquisition Corp. in the transaction. Flying Eagle Acquisition Corp. (NYSE: FEAC) (Flying Eagle), a publicly traded special-purpose acquisition company...
TCV’s Investment in Oversight
Simpson Thacher represented TCV in the transaction. TCV completed its acquisition of Oversight, the global leader in spend management technology. TCV will acquire a majority interest...
NCR’s $1.1 Billion High?Yield Senior Notes Offering
Cravath represented the initial purchasers in the transaction. NCR Corporation closed the offering of $650 million aggregate principal amount of 5.000% senior notes due 2028 and...
Hazel Health’s $32 Million Series C Financing Round
Latham & Watkins LLP represented Hazel Health in the transaction. Hazel Health, a pediatric telehealth provider, has raised a Series C funding round, led by Owl...
National Bank of Canada’s $500 Million Notes Offering
Osler, Hoskin & Harcourt LLP, working alongside McCarthy Tétrault LLP, advised National Bank of Canada on the deal. National Bank of Canada announced its $500 million...